Monkeypox outbreak is ‘containable,’ WHO says as it confirms more cases

Monkeypox outbreak is ‘containable,’ WHO says as it confirms more cases


Monkeypox cases are being investigated in Europe, the U.S., Canada and Australia following a recent spike in infections.

Jepayona Delita | Future Publishing | Getty Images

The World Health Organization said Tuesday that a recent outbreak of monkeypox cases in non-endemic countries is “containable,” even as it continues to confound health experts.

As of Tuesday, there were 131 confirmed cases and 106 suspected cases of the disease since the first was reported on May 7, according to the public health body. The cases are reportedly located in 19 countries outside of Africa.

The WHO said it was currently unclear whether the spike in cases was the “tip of the iceberg” or whether a peak in transmission had already been reached.

Monkeypox is a rare viral infection that is endemic to Central and West Africa. It spreads through close contact with people, animals or material infected with the virus, with symptoms including rashes, fever, headaches, muscle ache, swelling and backpain.

While most cases are mild, typically resolving within two to four weeks, health experts have been baffled by the recent spike in countries with no history of the disease and patients with no travel links to endemic countries.

Western cases rise, primarily through sex

At least 19 countries including the U.S., U.K. Canada, Australia, Italy, Spain and Portugal have so far reported cases. Belgium — currently home to four cases — on Friday became the first country to institute mandatory isolation for patients, while the U.K. has urged close contacts of patients to sell-isolate.

The majority of cases are spreading through sex, the WHO said Monday. Though not generally considered a sexually transmitted disease, health authorities have noted a particular concentration of cases among men who have sex with other men.

A section of skin tissue, harvested from a lesion on the skin of a monkey, that had been infected with monkeypox virus, is seen at 50X magnification on day four of rash development in 1968. 

CDC | Reuters

The Centers for Disease Control and Prevention on Monday alerted gay and bisexual men to take precautions if they have been in close contact with someone who may have the virus and to be on the lookout for symptoms.

“A notable proportion of recent cases in the UK and Europe have been found in gay and bisexual men so we are particularly encouraging these men to be alert to the symptoms,” Susan Hopkins, chief medical advisor at the U.K.’s Health Security Agency, added Monday.

Monkeypox strain mutation unlikely

The WHO’s Director for Global Infectious Hazard Preparedness, Sylvie Briand, said Tuesday that it’s unlikely the virus has mutated. Rather, she said, its transmission may have been driven by a change in human behavior, particularly as a result of easing Covid-19 social restrictions.

The West African strain of monkeypox — which has been identified in the current outbreak — has a mortality rate of around 1%.

“We encourage you all to increase the surveillance of monkeypox to see where transmission levels are and understand where it is going,” Briand added.

Jeremy Farrer, director of global health charity Wellcome, told CNBC Monday that the recent outbreak was atypical of the monkeypox virus.

“We’ve never had a [monkeypox] epidemic before which has spread now to 15 countries in three weeks,” Farrer said at the World Economic Forum.

However, he added that it should not yet be a cause for concern for the general public, noting that it is not yet a “Covid-style risk.”

“That’s not the same as saying public health people shouldn’t be worried. It’s not the same as saying we must not act swiftly. But is it a huge risk to the public? No, I don’t believe it is, as of today.”

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit
Health

2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit

The ripple is about to become a wave. Right now, there are numerous barriers for people who are considering treating their obesity with GLP-1 drugs. Early on, there were manufacturing bottlenecks that resulted in short supplies of Novo Nordisk ‘s Wegovy and Eli Lilly ‘s Zepbound. There were insurance coverage issues for these pricey treatments, […]

Read More
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More